Protection of visual function may signal disruption of mechanisms underlying diabetic retinopathy (DR)… This was a 6-month randomized, controlled clinical trial of patients with type 1 and type 2 diabetes with no retinopathy or mild to moderate non-proliferative retinopathy assigned to twice-daily consumption of placebo or a novel, multi-component formula …
Read More »Does Exercise Really Help Those with Type 2 Diabetes?
New analysis suggests either aerobics or strength training can improve blood sugar levels, lower body fat and waist size, more… In a randomized trial, researchers at the University of Texas Southwestern Medical Center at Dallas compared different strategies of exercise for people with type 2 diabetes. They found that people …
Read More »Liraglutide Reducing Postprandial Hyperglycemia Using Closed Loop System
Once-daily injection of liraglutide in closed-loop setting effective in decreasing postprandial hyperglycemia, hyperglucagonemia and insulin requirements….
Read More »Physical Activity Decreasing Risk of Comorbidities?
Exercise inversely correlated with HbA1c, diabetic ketoacidosis, BMI, and dyslipidemia in type 1 patients…. Barbara Bohn and colleagues from the University of Ulm in Germany looked at a cohort study with 18,028 adults with type 1 diabetes. Participants were classified according to their physical activity. The results of the study …
Read More »Sulfonylureas Increasing Lipids for Type 2 Diabetes Patients?
In the study, sulfonylureas correlated with a significant increase in levels of free fatty acids….
Read More »Time-Updated HbA1c Increases Risk of Heart Attack
Researchers found risk for myocardial infarction per 1% in higher HbA1c levels….
Read More »Combination Insulin Degludec, Liraglutide Bested Insulin Glargine
Once-daily, single-injection treatment lowered HbA1c levels, decreased body weight and reduced risk for hypoglycemia in type 2 patients…
Read More »Focused Care Improves Control Without Hypoglycemia Risk
Wearing a CGM on type 2 patients for 3 months improved control…
Read More »Can an SGLT-2 Inhibitor Be Used in Type 1 Diabetes?
SGLT-2 inhibitors are a new class of drug for the treatment of type 2 diabetes, but they are also being used off label in patients with type 1 diabetes.
Read More »The Affordable Care Act and Diabetes: Is There an Impact?
Increased access to healthcare can be beneficial to Medicaid recipients in expansion states…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.